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Introduction 
Chronic, irreversible pulmonary hypertension 
(PHT) caused by microembolization of foreign par- 
ticles to the lung interstitium and granulomatous 
obstruction of the pulmonary arteries has been 
described in long-term drug abusers (1,2). Lately, 
morphologic alterations of the pulmonary arteries 
unrelated to the injection of foreign material have 
been described in cocaine users that could be 
responsible for chronic PHT (3). 
However, to our knowledge, acute, reversible PHT 
in the absence of left ventricular dysfunction has not 
been reported in cocaine abusers. We report the case 
of a patient with severe symptomatic PHT, unassoci- 
ated with left ventricular failure, which was related 
to intravenous cocaine administration and resolved 
spontaneously after drug withdrawal. 
Case Report 
The patient, a 24-year-old woman, began injecting 
1 gday-’ of intravenous cocaine 2 months before 
admission. Following each injection, she had acute 
episodes of diffuse chest pain, palpitations, and short- 
ness of breath. Later, dyspnoea and chest tightness 
became continuous with considerable worsening in 
the last 3 days. She admitted intravenous heroin 
addition for 5 yr previously. She was also a heavy 
smoker but had no previous manifestations of 
chronic obstructive pulmonary disease, medical com- 
plications of her drug addition, or previous cardiac 
or systemic diseases. She reported chronic cough and 
mucous sputum production that had increased 
recently, but not fever. Physical examination revealed 
an afebrile woman in respiratory distress with 30 
respirations per minute. The jugular venous pressure 
was 3 cm and the pulse rate was 100 beats min - ‘. A 
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right S, gallop, prominent pulmonary S, sound, and 
a diastolic murmur on the pulmonary area were 
heard. The remainder of the physical examination 
was unremarkable. 
Blood cell counts and routine chemistry values 
were normal. Antibodies for HIV and blood cultures 
were negative. Sputum contained no pathogens, 
eosinophils or malignant cells. Arterial PO, was 
53 mmHg and PCO, was 28 mmHg. Chest X-ray 
showed normal lung fields, elevation of right hemi- 
diaphragm, right ventricular enlargement, and 
prominence of the main pulmonary arteries. An ECG 
disclosed sinus tachycardia, right deviation of the 
QRS axis, right ventricular hypertrophy and right 
ventricular strain pattern. An echocardiogram 
obtained on the first hospital day revealed marked 
right auricular and ventricular enlargement (49 and 
48 mm, respectively) with septal paradoxical move- 
ment, pulmonary and tricuspid valvular regurgita- 
tion, and normal left auricular and ventricular 
cavities (Plate 1). No valvular vegetations or struc- 
tural abnormalities were identified. The left ventricu- 
lar ejection fraction was 65% and the systolic 
pulmonary artery pressure was estimated to be 
72 mmHg. A reduced carbon monoxide diffusing 
capacity (DLCO) was the only abnormality found in 
pulmonary function tests. A combined ventilation/ 
perfusion lung scintiscan excluded pulmonary 
embolism. 
The patient received supplemental oxygen by face 
mask without medications. Two days after cocaine 
use was stopped, the patient felt much improved. 
Another echocardiogram obtained on the sixth 
hospital day showed a reduction in the size of the 
right cavities and in the degree of valvular regurgita- 
tions, and a pulmonary artery pressure of 44 mmHg. 
Arterial PO, breathing room air was 80 mmHg 
and PCO, was 40 mmHg, and the patient was 
discharged. Five weeks after admission, the patient 
was seen at our outpatient clinic. She denied cocaine 
use but admitted occasional injections of heroin. 
Physical examination abnormalities and gasometric 
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Plate I Transthoracic echocardiogram, short axis view (a), showing enlargement of the right ventricle and flattening of the 
interventricular septum. Continuous Doppler (b) showing tricuspid regurgitation with high velocity (3.85 m s - ‘). Lv, left 
ventricle; rv, right ventricle; PAP, pulmonary artery pressure; and TF, tricuspid flow. 
alterations had disappeared. An echocardiogram 
revealed normal right cavities and a pulmonary 
artery pressure of 34 mmHg (Plate 2). 
Discussion 
Cocaine, an a-adrenergic agonist, blocks the re- 
uptake of neurotransmitters such as norepinephrine, 
dopamine and serotonin at the synaptic junctions 
resulting in increased neurotransmitter concentra- 
tions and increased vascular tone among other auto- 
nomic effects (45). However, the effect of cocaine on 
the pulmonary vascular tone in humans is not clear 
(5). Although there is some evidence of PHT related 
to cocaine administration in both humans (6) and 
dogs (7), the increases in pulmonary pressures were 
secondary to left ventricular dysfunction. 
Some authors have suggested that the alveolar 
haemorrhage induced by cocaine could be due to 
pulmonary arterial vasoconstriction (8). On the other 
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Plate 2 Five weeks later, compression of the left ventricle had disappeared (a), and the pulmonary arterial pressure was 
normal (b). Lv, left ventricle; rv, right ventricle; PAP, pulmonary artery pressure; and TF, tricuspid flow. 
hand, pulmonary vasospasm, if chronic, could be 
responsible for the decrease in DLCO frequently 
found in these patients and, perhaps, of irreversible 
PHT (9). In fact, the presence of morphologic altera- 
tions in the pulmonary arteries of cocaine smokers in 
the absence of interstitial microembolizations has 
been well characterized in some reports (10) and in a 
series of necropsies (3). In the latter study, the 
incidence of medial hypertrophy of the muscular 
pulmonary arteries was found to be 20% (3). Thus, 
repeated episodes of acute PHT could be responsible 
for some cases of chronic PHT in these patients by 
promoting changes in the medial layer of the 
pulmonary arteries. In fact, this mechanism has 
been proposed for the pathogenesis of primary PHT 
(11). 
Pulmonary hypertension has been reported in four 
cocaine smokers with dyspnoea and intermittent hae- 
moptysis (10). However, the length of the patients’ 
addition (4-S yr) and the presence of vascular altera- 
tions in lung biopsies suggest that the PHT was not 
acute. Interestingly, the fact that all patients were 
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women while most of the cocaine users were men led 
the authors to suspect a predisposition for this 
disease in females. 
Dyspnoea, chest pain and palpitations are com- 
mon in primary PHT (12). These symptoms have also 
been frequently reported after cocaine use although 
their pathogenetic mechanisms are unclear (4,513). 
However, our patient presented with these symp- 
toms, which were temporally related to the use of 
cocaine, and definite evidence of acute PHT in the 
absence of other processes associated with secondary 
PHT including left ventricular failure (11). Finally, 
both the symptoms and the PHT resolved spontane- 
ously upon discontinuation of cocaine. Thus, it is 
possible that these symptoms might have been due to 
acute PHT and that such haemodynamic disturbance 
could be a frequent event in cocaine users. Prospec- 
tive studies with measurement of pulmonary and 
cardiac pressures are needed to define the frequency 
and clinical significance of this process. 
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